Brief: Cyclacel Pharmaceuticals Reports Fourth Quarter And Full Year 2021 Financial Results
March 28 (Reuters) - Cyclacel Pharmaceuticals Inc CYCC.O :
* CYCLACEL PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL
YEAR
2021 FINANCIAL RESULTS
* CYCLACEL PHARMACEUTICALS INC - ESTIMATES THAT AVAILABLE
CASH
RESOURCES WILL FUND CURRENTLY PLANNED PROGRAMS THROUGH MID-2023
* CYCLACEL PHARMACEUTICALS INC - NET LOSS FOR THREE MONTHS
ENDED
DECEMBER 31, 2021 WAS $5.3 MILLION
Source text for Eikon: ID:nGNXM3CdP
Further company coverage: CYCC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bio Green Med Solution
See all newsBrief: Bio Green Med Solution Announces Business Combination Agreement To Acquire Future NRG
Bio Green Med Solution Q1 product revenue hits $0.8 mln, net loss narrows
Brief: Bio Green Med Solution Inc Q1 Net Income USD -197 Thousand
Malaysia's Bio Green Med Solution Q4 net loss narrows
Brief: Bio Green Med Solution Inc Q4 Net Income USD -611 Thousand